Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Liposome-based delivery of small-interfering RNA (siRNA) has shown potential for gene silencing in the genital tract.
• Commercial transfection agents for siRNA can exhibit toxicity to mucosal epithelia and lack controlled release capabilities.

Purpose of the Study:

• To develop and evaluate biodegradable polymer nanoparticles as a safe and effective delivery system for siRNA to the vaginal mucosa.
• To assess the efficiency and duration of gene silencing following nanoparticle administration in the female reproductive tract.

Main Methods:

• Novel methods were developed to load biodegradable, FDA-approved nanoparticles with high concentrations of siRNA.
• Nanoparticles were administered via vaginal instillation to a mouse model.
• Gene expression knockdown was analyzed both proximally (vaginal lumen) and distally (uterine horns).
• Nanoparticle penetration into epithelial tissues was examined.

Main Results:

• A single dose of siRNA-loaded nanoparticles resulted in efficient and sustained gene silencing.
• Gene knockdown was observed in both vaginal and uterine tissues, indicating effective distal delivery.
• The nanoparticles demonstrated deep penetration into the vaginal epithelial tissue.
• The developed nanoparticles were found to be effective delivery vehicles for siRNA to the vaginal mucosa.

Conclusions:

• Biodegradable polymer nanoparticles represent a promising, non-toxic alternative for siRNA delivery to the vaginal mucosa.
• This nanoparticle system enables sustained gene silencing throughout the female reproductive tract.
• This study establishes a novel platform for vaginal gene therapy applications.